9 March 2016 in Journal of the American Heart Association
Background: The majority of women with angina‐like chest pain have no obstructive coronary artery disease when evaluated with coronary angiography. Coronary microvascular dysfunction is a possible explanation and associated with a poor prognosis. This study evaluated the prevalence of coronary microvascular dysfunction and the association with symptoms, cardiovascular risk factors, psychosocial factors, and results from diagnostic stress testing.Methods and Results: After screening 3568 women, 963 women with angina‐like chest pain and a diagnostic coronary angiogram without significant coronary artery stenosis (<50%) were consecutively included. Mean age (SD) was 62.1 (9.7). Assessment included demographic and clinical data, blood samples, questionnaires, and transthoracic echocardiography during rest and high‐dose dipyridamole (0.84 mg/kg) with measurement of coronary flow velocity reserve (CFVR) by Doppler examination of the left anterior descending coronary artery.CFVRwas successfully measured in 919 (95%) women. Median (IQR)CFVRwas 2.33 (1.98–2.76), and 241 (26%) had markedly impairedCFVR(<2). In multivariable regression analysis, predictors of impairedCFVRwere age (P<0.01), hypertension (P=0.02), current smoking (P<0.01), elevated heart rate (P<0.01), and low high‐density lipoprotein cholesterol (P=0.02), but these variables explained only a little of theCFVRvariation (r2=0.09).CFVRwas not associated with chest pain characteristics or results from diagnostic stress testing.Conclusion: ImpairedCFVRwas detected in a substantial proportion, which suggests that coronary microvascular dysfunction plays a role in the development of angina pectoris.CFVRwas associated with few cardiovascular risk factors, suggesting thatCFVRis an independent parameter in the risk evaluation of these women. Symptom characteristics and results from stress testing did not identify individuals with impairedCFVR.
1 March 2018 in International Journal of Cardiology
1 April 2017 in Psychosomatic Medicine
Objective: The construct of vital exhaustion has been identified as a potential independent psychological risk factor for incident and recurrent coronary heart disease (CHD). Despite several decades of research, no systematic review or meta-analysis has previously attempted to collate the empirical evidence in this field. The purpose of this study was to review and quantify the impact of vital exhaustion on the development and progression of CHD. Methods: Prospective and case-control studies reporting vital exhaustion at baseline and CHD outcomes at follow-up were derived from PubMed, PsycINFO (1980 to July 2015; articles in English and published articles only), and bibliographies. Information on aim, study design, sample size, inclusion and exclusion criteria, assessment methods of psychological risk factors, and results of crude and adjusted regression analyses were abstracted independently by two authors. Results: Thirteen prospective (n = 52,636) and three case-control (cases, n = 244; controls, n = 457) studies assessed vital exhaustion and could be summarized in meta-analyses. The pooled adjusted risk of CHD in healthy populations was 1.50 (95% confidence interval [CI] = 1.22–1.85) for prospective studies, and 2.61 (95% CI = 1.66–4.10) for case-control studies using hospital controls. Risk of recurrent events in patients with CHD was 2.03 (95% CI = 1.54–2.68). The pooled adjusted risk of chronic heart failure in healthy populations was 1.37 (95% CI = 1.21–1.56), but this was based on results from only two studies. Conclusions: Vital exhaustion is associated with increased risk of incident and recurrent CHD.
29 June 2016 in Current Pharmaceutical Design
Background: Cardiovascular disease has been the leading cause of death in both sexes in developed countries for decades. In general, men and women share the same cardiovascular risk factors. However, in recent trials including both men and women sex-specific analyses have raised awareness of sex differences in cardiovascular risk factors due to both biological and cultural differences. Results: Women experience their first myocardial infarction (MI) 6-10 years later than men and a protective effect of their natural estrogen status prior to menopause has been suggested. Female sex hormones have been associated with a less atherogenic lipid profile and a more healthy fat distribution. These differences are attenuated following menopause. Regarding life style the prevalence of smoking is highest in men but female smokers have a relatively higher cardiovascular risk than male smokers. Men are more physically active than women while women have healthier dietary habits. Genetic factors also affect cardiovascular risk but no sex differences have been seen. Increased cardiovascular risk attributed to psychosocial distress is similar in men and women, but since women are more prone to psychosocial distress their burden of disease is greater. Compared with a healthy population the relative risk of MI in a diabetic population is higher in women than in men. No sex difference exists in the prevalence of hypertension but it has an earlier onset in men. Conclusion: Sex differences in cardiovascular risk are becoming more apparent and paying attention to this is pivotal when addressing risk factors in preventive efforts.
1 July 2016 in Journal of the American Society of Echocardiography
1 April 2016 in JACC: Cardiovascular Imaging